INTRODUCTION: Hepatocellular adenoma (HA) is an uncommon benign hepatic tumour with the potential for malignant change or spontaneous haemorrhage. Resection has been the recommended treatment, but outcomes with other approaches are ill defined. METHODS: Demographic and outcomes data were retrospectively collected on patients diagnosed with HA at a tertiary hepatobiliary centre from 1992-2011 whom underwent resection, bland embolization or observation. RESULTS: In total, 52 patients with 100 adenomas were divided into single HA (n = 27), multiple HA (n = 18), and adenomatosis (n = 7) groups. Eighty-seven per cent were female and 37% had a history of hormone use. Median sizes of resected, embolized and observed adenomas were 3.6 cm, 2.6 cm and 1.2 cm, respectively. Forty-eight adenomas were resected as a result of suspicion of malignancy (39%) or large size (39%); 61% of these were solitary. Thirty-seven were embolized for suspicion of malignancy (56%) or hsemorrhage (20%); 92% of these were multifocal. Two out of three resected adenomas with malignancy were ≥10 cm and recurred locally [4%, confidence interval (CI) 1-14%]. Ninety-two per cent of the embolized adenomas were effectively treated; three persisted (8.1%, CI 2-22%). Most observed lesions did not change over time. CONCLUSIONS: While solitary adenomas are often resected, multifocal HAs are frequently embolized. Small adenomas can safely be observed. Given low recurrence rates, select HAs can be considered for embolization.
INTRODUCTION:Hepatocellular adenoma (HA) is an uncommon benign hepatic tumour with the potential for malignant change or spontaneous haemorrhage. Resection has been the recommended treatment, but outcomes with other approaches are ill defined. METHODS: Demographic and outcomes data were retrospectively collected on patients diagnosed with HA at a tertiary hepatobiliary centre from 1992-2011 whom underwent resection, bland embolization or observation. RESULTS: In total, 52 patients with 100 adenomas were divided into single HA (n = 27), multiple HA (n = 18), and adenomatosis (n = 7) groups. Eighty-seven per cent were female and 37% had a history of hormone use. Median sizes of resected, embolized and observed adenomas were 3.6 cm, 2.6 cm and 1.2 cm, respectively. Forty-eight adenomas were resected as a result of suspicion of malignancy (39%) or large size (39%); 61% of these were solitary. Thirty-seven were embolized for suspicion of malignancy (56%) or hsemorrhage (20%); 92% of these were multifocal. Two out of three resected adenomas with malignancy were ≥10 cm and recurred locally [4%, confidence interval (CI) 1-14%]. Ninety-two per cent of the embolized adenomas were effectively treated; three persisted (8.1%, CI 2-22%). Most observed lesions did not change over time. CONCLUSIONS: While solitary adenomas are often resected, multifocal HAs are frequently embolized. Small adenomas can safely be observed. Given low recurrence rates, select HAs can be considered for embolization.
Authors: Ajita Deodhar; Lynn A Brody; Anne M Covey; Karen T Brown; George I Getrajdman Journal: J Vasc Interv Radiol Date: 2011-06 Impact factor: 3.464
Authors: C Bunchorntavakul; R Bahirwani; D Drazek; M C Soulen; E S Siegelman; E E Furth; K Olthoff; A Shaked; K R Reddy Journal: Aliment Pharmacol Ther Date: 2011-07-15 Impact factor: 8.171
Authors: Jeremiah L Deneve; Timothy M Pawlik; Steve Cunningham; Bryan Clary; Srinevas Reddy; Charles R Scoggins; Robert C G Martin; Michael D'Angelica; Charles A Staley; Michael A Choti; William R Jarnagin; Richard D Schulick; David A Kooby Journal: Ann Surg Oncol Date: 2009-01-08 Impact factor: 5.344
Authors: Deha Erdogan; Otto M van Delden; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik Journal: Cardiovasc Intervent Radiol Date: 2007 Nov-Dec Impact factor: 2.740
Authors: Yun Shin Chun; Robin J Parker; Subbarao Inampudi; Eduardo Ehrenwald; Kenneth P Batts; Lawrence J Burgart; Clark W Schumacher; Jason A Mehling; Bjorn I Engstrom; Mark J Hill; Srinevas K Reddy; Timothy D Sielaff Journal: J Gastrointest Surg Date: 2015-09-16 Impact factor: 3.452
Authors: Sun Young Ahn; Soo Young Park; Young Oh Kweon; Won Young Tak; Han Ik Bae; Seung Hyun Cho Journal: World J Gastroenterol Date: 2013-11-14 Impact factor: 5.742
Authors: Belle V van Rosmalen; Matthanja Bieze; Marc G H Besselink; Pieter Tanis; Joanne Verheij; Saffire S K S Phoa; Olivier Busch; Thomas M van Gulik Journal: HPB (Oxford) Date: 2016-08-21 Impact factor: 3.647
Authors: Ser Yee Lee; T Peter Kingham; Maria D LaGratta; Jose Jessurun; Daniel Cherqui; William R Jarnagin; Michael D Kluger Journal: HPB (Oxford) Date: 2015-12-11 Impact factor: 3.647